Figure 2.
(A) Multiple nodules consistent with cutaneous squamous cell carcinoma on the left temporal area before starting cemiplimab; (B) tumor regression after three cycles of cemiplimab; (C) response after a total of 10 cycles of cemiplimab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.